conceptus


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

conceptus

[kən′sep·təs]
(biology)
The product of a conception, including the embryo or fetus and extraembryonic membranes, at any stage of development from fertilization to birth.
Mentioned in ?
References in periodicals archive ?
As a result of the purchase of shares in the tender offer, a merger between Conceptus and a Bayer subsidiary is planned to be effected imminently, giving Bayer full ownership of Conceptus.
Through the addition of Conceptus, which has developed the Essure procedure, a surgery-free and hormone-free permanent birth control method that has been approved by the US Food and Drug Administration (FDA), Bayer will be able to provide a comprehensive range of contraceptive choices for women, the German firm said.
Although Judge William Alsup of the Northern District of California District Court denied the Conceptus motion for permanent injunction, which was designed to permanently block Hologic's sales of its Adiana system in the US and denied Conceptus' supplemental damages request, he allowed Conceptus to file a supplemental complaint seeking damages since 30 June 2011.
We are very pleased to have received Canadian approval almost a full year ahead of our expected timeline," stated Cindy Domecus, senior vice president of Clinical Research & Regulatory Affairs for Conceptus.
Both Bayer and Conceptus are focusing on innovative solutions to advance women's healthcare.
00 per share cash tender offer for all Conceptus shares within the next ten business days.
Conceptus, based in California, developed the Essure procedure, a non-surgical permanent birth control technique.
Conceptus further said that the jury has awarded it USD18.
The transaction was made by Conceptus' new Netherlands-based subsidiary, Conceptus BV.
75%, and is available for immediate drawdown, subject to certain financial covenants and other restrictions, Conceptus said.
We continue to believe that at trial we will win on the merits of our case and prove conclusively that the Adiana system infringes our patents," commented Mark Sieczkarek, president and chief executive officer of Conceptus.
Under the 2003 Settlement Agreement, Conceptus had been making royalty payments to AMS equal to 3.